BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35662120)

  • 21. Multicenter
    Rullmann M; Brendel M; Schroeter ML; Saur D; Levin J; Perneczky RG; Tiepolt S; Patt M; Mueller A; Villemagne VL; Classen J; Stephens AW; Sabri O; Barthel H; On Behalf Of The German Imaging Initiative For Tauopathies Gii T
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology.
    Stratmann K; Heinsen H; Korf HW; Del Turco D; Ghebremedhin E; Seidel K; Bouzrou M; Grinberg LT; Bohl J; Wharton SB; den Dunnen W; Rüb U
    Brain Pathol; 2016 May; 26(3):371-86. PubMed ID: 26193084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TCR CDR3-antigen chemical complementarity associated with poor ovarian cancer outcomes: A vestigial immune response to early cancer antigens?
    Barker VR; Varkhedi M; Patel DN; Hsiang M; Chobrutskiy A; Chobrutskiy BI; Blanck G
    Am J Reprod Immunol; 2023 Jan; 89(1):e13639. PubMed ID: 36317868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical features of melanoma tumor resident TRG CDR3s associated with better survival probabilities.
    Agnila DRL; Huda TI; Eakins RA; Patel DN; Hsiang M; Chobrutskiy A; Chobrutskiy BI; Blanck G
    Melanoma Res; 2023 Aug; 33(4):275-282. PubMed ID: 37222076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hierarchical Distribution of the Tau Cytoskeletal Pathology in the Thalamus of Alzheimer's Disease Patients.
    Rüb U; Stratmann K; Heinsen H; Del Turco D; Ghebremedhin E; Seidel K; den Dunnen W; Korf HW
    J Alzheimers Dis; 2016; 49(4):905-15. PubMed ID: 26519431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression.
    Pakasticali N; Chobrutskiy A; Patel DN; Hsiang M; Zaman S; Cios KJ; Blanck G; Chobrutskiy BI
    Cancer Inform; 2023; 22():11769351231177269. PubMed ID: 37313373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
    Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between subcortical tau pathology and Alzheimer's disease.
    Attems J; Thal DR; Jellinger KA
    Biochem Soc Trans; 2012 Aug; 40(4):711-5. PubMed ID: 22817721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen.
    Cheng P; Cios KJ; Varkhedi M; Barker VR; Yeagley M; Chobrutskiy A; Chobrutskiy BI; Blanck G
    Oncoscience; 2023; 10():59-66. PubMed ID: 37953875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olfactory involvement in aging and Alzheimer's disease: an autopsy study.
    Attems J; Lintner F; Jellinger KA
    J Alzheimers Dis; 2005 Apr; 7(2):149-57; discussion 173-80. PubMed ID: 15851853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune receptor CDR3 chemical features that preserve sequence information are highly efficient in reflecting survival distinctions: A pan-cancer analysis.
    Mcbreairty BE; Chobrutskiy BI; Chobrutskiy A; Gozlan EC; Diaz MJ; Blanck G
    Biomed Rep; 2022 Aug; 17(2):68. PubMed ID: 35815190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tau pathology and cognitive reserve in Alzheimer's disease.
    Hoenig MC; Bischof GN; Hammes J; Faber J; Fliessbach K; van Eimeren T; Drzezga A
    Neurobiol Aging; 2017 Sep; 57():1-7. PubMed ID: 28577411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations between cortical and subcortical tau pathology.
    Attems J; Thomas A; Jellinger K
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):582-90. PubMed ID: 22115520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
    Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
    Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.
    Ercan-Herbst E; Ehrig J; Schöndorf DC; Behrendt A; Klaus B; Gomez Ramos B; Prat Oriol N; Weber C; Ehrnhoefer DE
    Acta Neuropathol Commun; 2019 Dec; 7(1):192. PubMed ID: 31796124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Networks of tau distribution in Alzheimer's disease.
    Hoenig MC; Bischof GN; Seemiller J; Hammes J; Kukolja J; Onur ÖA; Jessen F; Fliessbach K; Neumaier B; Fink GR; van Eimeren T; Drzezga A
    Brain; 2018 Feb; 141(2):568-581. PubMed ID: 29315361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.